drugset / Trial / NCT02961673
The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines
RandomizedParallel-groupDouble-blindTreatment
Summary
A Phase I/Ⅱ Clinical Trial to Compare the Safety and Efficacy of HU-014 versus Botox® in Subject with Moderate to Severe Glabellar Lines
Timeline
- Start
- 2016-09
- Primary completion
- 2017-02
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 20 iu | Intramuscular |
| Subject | HU-014 | Unknown | 20 iu | Intramuscular |
Indications
No indication recorded.